In contrast, we also found that CELF2 was lower in bladder, brain and central nervous system, breast, head and neck, lung, lymphoma, ovarian, prostate and sarcoma cancers compared with normal tissues (Figure 1A). Here, CELF2 is linked to lymphoma.